FMR LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,440
+168.8%
6,400
+60.0%
0.00%
Q2 2022$5,000
+66.7%
4,000
+97.5%
0.00%
Q1 2022$3,0002,025
+4400.0%
0.00%
Q4 2021$0450.0%0.00%
Q3 2021$045
+4400.0%
0.00%
Q2 2021$0
-100.0%
1
-99.9%
0.00%
Q1 2021$3,0001,500
+9275.0%
0.00%
Q3 2019$0160.0%0.00%
Q2 2019$0
-100.0%
16
-98.0%
0.00%
Q4 2018$3,000
-40.0%
8000.0%0.00%
Q3 2018$5,0008000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Benchmark Capital Advisors 221,700$1,051,0000.83%
EAM Global Investors LLC 227,063$1,076,0000.56%
EAM Investors, LLC 319,187$1,513,0000.25%
COURAGE CAPITAL MANAGEMENT LLC 30,000$142,0000.11%
Cutter & CO Brokerage, Inc. 53,600$254,0000.10%
SABBY MANAGEMENT, LLC 286,800$1,360,0000.08%
D.A. DAVIDSON & CO. 731,300$3,466,0000.07%
Tibra Equities Europe Ltd 63,414$301,0000.05%
Advisor Group, Inc. 556,377$2,637,0000.04%
Laurel Wealth Advisors, Inc. 21,400$101,0000.03%
View complete list of GALECTIN THERAPEUTICS INC shareholders